Protagonist Therapeutics Inc. (PTGX)
Market Closed
27 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
55. 69
+0.47
+0.86%
After Hours
$
-2.27 -4.08% 53. 42
3.45B Market Cap
- P/E Ratio
0% Div Yield
1,547,400 Volume
0.75 Eps
$ 55.22
Previous Close Day Range
54.7 55.9
Year Range
31.34 60.6
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| PTGX Protagonist Therapeutics Inc. 5 May 2025 | | 0.11 Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 25 Feb 2025 | | 0.25 Cons. EPS | 1.98 EPS |
| PTGX Protagonist Therapeutics Inc. 4 Nov 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 31 Oct 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 5 Aug 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 1 Aug 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 20 Jun 2024 | | 1.19 Cons. EPS | 3.26 EPS |
| PTGX Protagonist Therapeutics Inc. 7 May 2024 | | 1.19 Cons. EPS | 3.26 EPS |
| PTGX Protagonist Therapeutics Inc. 2 May 2024 | | 1.19 Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 27 Feb 2024 | | - Cons. EPS | 0.44 EPS |
| PTGX Protagonist Therapeutics Inc. 6 Nov 2023 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 2 Nov 2023 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 14 Nov 2016 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 12 Aug 2016 | | - Cons. EPS | - EPS |
PTGX Earnings Reports FAQ
What is the earnings per share (EPS) for PTGX?
The current EPS is 0.75.
2025 © Marketlog. All Rights Reserved.
